Sanofi

Paris, Francewww.sanofi.com1expert edge

Global biopharmaceutical company specializing in R&D-driven development of medicines, vaccines, and healthcare solutions across immunology, oncology, neurology, rare diseases, and vaccines.

Why interesting to a deal team

Large pharma acquirer (Principia Biopharma $3.7B) demonstrating active M&A in biopharma; strategic buyer of late-stage biotech assets for therapeutic expansion.

Experts connected to this company

Israel AkinrinsolaAdvised Sanofi on Principia Biopharma acquisition

Israel Akinrinsola

Managing Director, Healthcare Strategic Advisory

Evercore

BankerLondon

London-based Evercore healthcare banker with a live track record on pharma services, CDMO capacity, and specialty pharma carve-outs across Europe's largest 2019-2024 deals.

Sources

Page titlePrimary
sanofi.com/en/media-room/press-releases/2020/2020-09-28-13-30-00-2099966
Page titlePrimary
sanofi.com

Strongest evidencePage title2 public sourcesHow the grades work